Archive for January 21st, 2009
-
Jan 21, 2009
No CommentsNew study provides further evidence that apple juice can delay onset of alzheimer’s disease
(IOS Press) A growing body of evidence demonstrates that we can take steps to delay age-related cognitive decline, including in some cases that which accompanies Alzheimer's disease, according to a study published in the January 2009 issue of the Journal of Alzheimer's Disease. (Source: EurekAlert! -...
-
Jan 21, 2009
No CommentsRegional white matter integrity differentiates between vascular dementia and alzheimer disease.
CONCLUSIONS: Integrating mean FA in the forceps minor to the Fazekas score provides a useful quantitative marker for differentiating AD from VaD. PMID: 19164789 [PubMed - as supplied by publisher] (Source:...
-
Jan 21, 2009
No CommentsThe neuronal expression of myc causes a neurodegenerative phenotype in a novel transgenic mouse.
The Neuronal Expression of MYC Causes a Neurodegenerative Phenotype in a Novel Transgenic Mouse. Am J Pathol. 2009 Jan 22; Authors: Lee HG, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, Perry G, Felsher DW, Petersen RB, Smith MA Many different proteins associated with...
-
Jan 21, 2009
No CommentsSage journals archive collection
We are pleased to inform you that access is now available to the SAGE Journals Archive Collection. The purchase was funded by several campus libraries including the Historical Medical and Nursing Libraries, and provides access back to volume 1 for 353 SAGE journals. Among the journals with archival access are: American Journal...
-
Jan 21, 2009
No CommentsMetabolic syndrome linked to vascular dementia
Individuals with metabolic syndrome -- a cluster of risk factors for heart disease and diabetes -- may also have an increased risk of developing "vascular" dementia, but not Alzheimer's...
-
Jan 21, 2009
No CommentsFDA issues warning about skin-numbing drugs
The U.S. Food and Drug Administration has issued a warning to healthcare providers and consumers about serious and life-threatening risks associated with improper use of prescription and over-the-counter topical...
-
Jan 21, 2009
1 CommentAlzheimer’s Drug Discovery Foundation Funds Edunn Biotechnology To Develop Treatment For Alzheimer’s Disease
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it is providing a grant of $100,000 to Edunn Biotechnology, Inc., an early stage company dedicated to developing a novel class of drugs to treat and prevent Alzheimer's disease (AD)....
-
Jan 21, 2009
No CommentsAlzheimer’s drug discovery foundation: alzheimer’s drug discovery foundation funds development of clinical tests for alzheimer’s disease
NEW YORK, NY (MARKET WIRE) The Alzheimer's Drug Discovery Foundation (ADDF) awarded the British firm of Cambridge Cognition Ltd. a grant of $200,000 to assist in their development of a clinical cognitive assessment product for Alzheimer's disease. ADDF made this award as part of its effort to advance early detection and the reliable assessment of...
-
Jan 21, 2009
No CommentsAlzheimer’s drug discovery foundation funds edunn biotechnology to develop treatment for alzheimer’s disease
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it is providing a grant of $100,000 to Edunn Biotechnology, Inc., an early stage company dedicated to developing a novel class of drugs to treat and prevent Alzheimer's disease (AD). (Source: Health News from Medical News...
-
Jan 21, 2009
No CommentsInterleukin-1a –889 c/t polymorphism in turkish patients with late-onset alzheimer’s disease
Dement Geriatr Cogn Disord 2009;27:82-87 (DOI:10.1159/000193627) (Source: Dementia and Geriatric Cognitive Disorders)MedWorm Message: Find out how you can get your message across here by sponsoring this MedWorm news...
